- IMPDInvestigational Medicinal Product Dossier
- Investigational planAn investigational plan is a medicines development plan to support the authorisation of a medicine for humans. It aims to ensure that the necessary data is obtained through clinical and other studies.
- InvestigatorA clinical trial investigator is responsible for the conduct of the trial at a trial site. If a trial is conducted by a team of individuals at a trial site, the investigator is the leader responsible for the team, and is called the principle investigator.
- Investigator’s BrochureThe Investigator's Brochure (IB) is a comprehensive document that summarises all the relevant clinical and non-clinical information about the medicine being studied in humans. An IB contains a 'Summary of Data and Guidance for the Investigator' section, the aim of which is 'to provide the(...)
- IBThe Investigator's Brochure (IB) is a comprehensive document that summarises all the relevant clinical and non-clinical information about the medicine being studied in humans. An IB contains a 'Summary of Data and Guidance for the Investigator' section, the aim of which is 'to provide the(...)
- Japan Pharmaceutical Manufacturers AssociationJapan Pharmaceutical Manufacturers Association http://www.jpma.or.jp"
- JPMAJapan Pharmaceutical Manufacturers Association http://www.jpma.or.jp"
- Slovenian National Competent Authority. http://www.jazmp.si/en/"
- Javna Agencija RS za zdravila in Medicinske PripomočkeSlovenian National Competent Authority. http://www.jazmp.si/en/"
- Joint Clinical Assessment (JCA)The JCA is the scientific compilation and the description of a comparative analysis of the available clinical evidence on a health technology in comparison with one or more other health technologies or existing procedures – the full definition is provided under Chapter I Article 2 (6) in the(...)